These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 374734)

  • 41. HLA-DR, DQ and DP antigen expression in synovial fluid T lymphocytes in rheumatoid arthritis: cell cycle analysis of HLA-DP positive T cells.
    Hirose T; Goto M; Okumura K
    J Rheumatol; 1990 Jan; 17(1):18-23. PubMed ID: 1690301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenesis of progressive systemic sclerosis.
    Postlethwaite AE; Kang AH
    J Lab Clin Med; 1984 Apr; 103(4):506-10. PubMed ID: 6607964
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical associations of fibroblast growth promoting factor in scleroderma.
    Potter SR; Bienenstock J; Lee P; Wilkinson S; Buchanan WW
    J Rheumatol; 1984 Feb; 11(1):43-7. PubMed ID: 6699832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte markers in patients with progressive systemic sclerosis.
    Czirják L; Dankó K; Sonkoly I; Bodolay E; Szegedi G
    Acta Med Hung; 1985; 42(3-4):109-14. PubMed ID: 2937012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Variability of the clinical picture and the classification of progressive systemic scleroderma].
    Giordano M; Ara M; Capelli L; Tirri G; Vatti M
    Z Rheumatol; 1976; 35(7-8):286-300. PubMed ID: 961080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
    Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
    Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulatory response towards the 65 kDa heat shock protein and other mycobacterial antigens in patients with rheumatoid arthritis.
    Burmester GR; Altstidl U; Kalden JR; Emmrich F
    J Rheumatol; 1991 Feb; 18(2):171-6. PubMed ID: 2023211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cellular immune phenomena in rheumatoid arthritis].
    Ryzewska A
    Reumatologia; 1976; 14(3):299-305. PubMed ID: 62376
    [No Abstract]   [Full Text] [Related]  

  • 49. Lowered angiogeneic capability of peripheral blood lymphocytes in progressive systemic sclerosis (scleroderma).
    Kaminski MJ; Majewski S; Jablonska S; Pawinska M
    J Invest Dermatol; 1984 Mar; 82(3):239-43. PubMed ID: 6199433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral blood lymphocyte distribution in scleroderma.
    Carapeto FJ; Winkelmann RK
    Dermatologica; 1975; 151(4):228-35. PubMed ID: 773715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cellular immunity in systemic scleroderma (author's transl)].
    Hattori A
    Nihon Hifuka Gakkai Zasshi; 1978 Apr; 88(5):347-58. PubMed ID: 149207
    [No Abstract]   [Full Text] [Related]  

  • 52. Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.
    Ferrarini M; Steen V; Medsger TA; Whiteside TL
    Clin Exp Immunol; 1990 Mar; 79(3):346-52. PubMed ID: 1969335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thymus-dependent (T) lymphocyte deficiency in progressive systemic sclerosis.
    Hughes P; Holt S; Rowell NR; Dodd J
    Br J Dermatol; 1976 Nov; 95(5):469-73. PubMed ID: 1086678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin resident memory T-cell population is not constructed effectively in systemic sclerosis.
    Koguchi-Yoshioka H; Watanabe R; Fujisawa Y; Ishitsuka Y; Nakamura Y; Okiyama N; Fujimoto M
    Br J Dermatol; 2019 Jan; 180(1):219-220. PubMed ID: 30120898
    [No Abstract]   [Full Text] [Related]  

  • 56. T-cell receptors in scleroderma skin. The effect of photopheresis.
    Williams WV; Rook AH; Freundlich BF; Fang Q; Shaw E; Lessin S; Weiner DB
    Ann N Y Acad Sci; 1995 Jul; 756():424-7. PubMed ID: 7645864
    [No Abstract]   [Full Text] [Related]  

  • 57. [Systemic scleroderma].
    Sollberg S; Krieg T
    Hautarzt; 1995 Aug; 46(8):587-601; quiz 600-1. PubMed ID: 7558832
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum levels of mannose-binding lectin in systemic sclerosis: a possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtype.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Eur J Dermatol; 2014; 24(1):123-5. PubMed ID: 24566202
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical significance of lymphocyte responsiveness to scleroderma-inducing glycosaminoglycan-associated antigen in systemic scleroderma.
    Tamura T; Ishikawa H
    Dermatologica; 1985; 171(6):435-41. PubMed ID: 4092798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration.
    Kahaleh MB; LeRoy EC
    Ann Intern Med; 1989 Mar; 110(6):446-50. PubMed ID: 2784042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.